dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

dsm-firmenich Switzerland Netherlands United Kingdom India United States of America

to learn more.

For more information

Media relations
Robin Roothans
tel. [phone]
e-mail [e-mail]

Investor relations
Dave Huizing
tel. [phone]
e-mail [e-mail]

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo - https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-to-sell-meg-3-fish-oil-business-to-kd-pharma-group-302200689.html